Current and historical daily PE Ratio for HAE (
Haemonetics Corp
) from 1991 to May 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Haemonetics stock (HAE) PE ratio as of May 15 2024 is 39.58.
More Details
Haemonetics Corp (HAE) PE Ratio (TTM) Chart
Haemonetics Corp (HAE) PE Ratio (TTM) Historical Data
View and export this data going back to 1991. Start your Free Trial
Total 1229
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Haemonetics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-15 | 39.6 | 2024-03-12 | 31.3 |
| 2024-05-14 | 39.6 | 2024-03-11 | 31.9 |
| 2024-05-13 | 39.1 | 2024-03-08 | 32.4 |
| 2024-05-10 | 39.0 | 2024-03-07 | 31.6 |
| 2024-05-09 | 37.6 | 2024-03-06 | 31.5 |
| 2024-05-08 | 37.9 | 2024-03-05 | 31.1 |
| 2024-05-07 | 38.7 | 2024-03-04 | 30.4 |
| 2024-05-06 | 38.8 | 2024-03-01 | 30.1 |
| 2024-05-03 | 38.4 | 2024-02-29 | 29.7 |
| 2024-05-02 | 37.9 | 2024-02-28 | 30.4 |
| 2024-05-01 | 37.5 | 2024-02-27 | 30.2 |
| 2024-04-30 | 37.4 | 2024-02-26 | 29.8 |
| 2024-04-29 | 37.2 | 2024-02-23 | 29.9 |
| 2024-04-26 | 37.0 | 2024-02-22 | 30.4 |
| 2024-04-25 | 35.6 | 2024-02-21 | 29.8 |
| 2024-04-24 | 35.0 | 2024-02-20 | 29.0 |
| 2024-04-23 | 34.6 | 2024-02-16 | 29.4 |
| 2024-04-22 | 34.0 | 2024-02-15 | 29.2 |
| 2024-04-19 | 33.0 | 2024-02-14 | 29.0 |
| 2024-04-18 | 33.9 | 2024-02-13 | 29.1 |
| 2024-04-17 | 34.5 | 2024-02-12 | 30.4 |
| 2024-04-16 | 34.2 | 2024-02-09 | 30.2 |
| 2024-04-15 | 34.5 | 2024-02-08 | 31.8 |
| 2024-04-12 | 34.6 | 2024-02-07 | 31.4 |
| 2024-04-11 | 35.2 | 2024-02-06 | 31.3 |
| 2024-04-10 | 35.0 | 2024-02-05 | 30.6 |
| 2024-04-09 | 35.4 | 2024-02-02 | 31.0 |
| 2024-04-08 | 34.7 | 2024-02-01 | 31.7 |
| 2024-04-05 | 34.4 | 2024-01-31 | 31.1 |
| 2024-04-04 | 34.5 | 2024-01-30 | 32.6 |
| 2024-04-03 | 34.1 | 2024-01-29 | 33.1 |
| 2024-04-02 | 34.2 | 2024-01-26 | 33.0 |
| 2024-04-01 | 34.5 | 2024-01-25 | 33.0 |
| 2024-03-28 | 34.7 | 2024-01-24 | 33.2 |
| 2024-03-27 | 34.2 | 2024-01-23 | 34.0 |
| 2024-03-26 | 33.2 | 2024-01-22 | 34.5 |
| 2024-03-25 | 33.3 | 2024-01-19 | 34.1 |
| 2024-03-22 | 32.6 | 2024-01-18 | 33.9 |
| 2024-03-21 | 32.6 | 2024-01-17 | 33.6 |
| 2024-03-20 | 32.5 | 2024-01-16 | 33.6 |
| 2024-03-19 | 31.5 | 2024-01-12 | 33.7 |
| 2024-03-18 | 30.8 | 2024-01-11 | 33.7 |
| 2024-03-15 | 30.4 | 2024-01-10 | 34.0 |
| 2024-03-14 | 30.7 | 2024-01-09 | 33.8 |
| 2024-03-13 | 31.0 | 2024-01-08 | 34.6 |
Haemonetics Corp (HAE) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Haemonetics Corp
NAICS : 339112
SIC : 3841
ISIN : US4050241003
Share Class Description:
HAE: Ordinary SharesDescription
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers